综合分析西班牙多发性硬化症住院趋势 (1998-2022)
Lucía Cayuela1, Cristina García-Muñoz2, Aurelio Cayuela3
1Department of Internal Medicine, Hospital Severo Ochoa, Leganés, Spain.
Multiple sclerosis and related disorders
|September 18, 2024
概括
在西班牙,多发性硬化症 (MS) 住院率从1998年到2022年有所下降. 这一趋势受到年龄,出生队列和性别的影响,尽管人口老龄化.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 多发性硬化症 (MS) 是一种慢性神经系统疾病.
- 了解住院趋势对于医疗保健规划至关重要.
- 西班牙有大量受MS影响的人口.
研究的目的:
- 分析1998年至2022年西班牙MS住院率的趋势.
- 调查年龄,周期和出生队列 (APC) 对这些趋势的影响.
- 确定与MS住院风险相关的人口因素.
主要方法:
- 使用西班牙国家卫生系统最低基本数据集 (CMBD) 的回顾性研究.
- 使用了年龄标准化住院率 (ASHR) 和joinpoint分析.
- 进行了年龄-周期-队列 (A-P-C) 分析,以评估特定的影响.
主要成果:
- 在西班牙,多发性硬化症住院人数每年下降2.1% (1998-2022年).
- 女性的下降率比男性 (-1.7%) 大 (-2.3%) .
- 住院的风险在年轻的成年人年龄组达到顶峰,并随着年龄的增长而下降,女性的风险比率更高.
结论:
- 尽管人口老龄化,但西班牙的多发性硬化症住院率有所下降.
- 住院风险受个人年龄,出生队列,医疗保健历史背景和性别的影响.
- 这些发现强调了MS流行病学的动态性质以及需要量身定制的医疗保健策略.
相关概念视频
Steps in Outbreak Investigation
108
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
108
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Interpreting Run Charts
91
Run charts, essentially line graphs plotted over time, serve as fundamental yet effective tools for process analysis. They chronicle data sequentially, facilitating the identification of trends, shifts, or cyclical movements. This graphical representation is instrumental in determining whether a process is stable or exhibits signs of potential instability indicative of special cause variation. In the healthcare domain, run charts depict infection rates over time, enabling hospitals to monitor...
91
Comparing the Survival Analysis of Two or More Groups
158
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
158
Pareto Chart
6.7K
A Pareto chart is a bar graph or a combination of both line and bar graphs. The bar lengths represent the individual values or the frequency, while the lines represent the cumulative total values. In this chart, the longest bars are arranged on the left and the shortest bars on the right, which makes it easier to read and interpret the data. It can also be called a Pareto diagram or Pareto analysis.
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
6.7K
Cancer Survival Analysis
331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331


